Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

FGFR1 Gene (Kallmann Syndrome Type 2) Genetic Test

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing, employing Next-Generation Sequencing with full gene coverage.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance by DHA-licensed specialists for result interpretation and next steps.
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.

Test Overview & Methodology

The FGFR1 gene test uses Next-Generation Sequencing (NGS) to detect pathogenic variants causing Kallmann syndrome type 2, a genetic form of hypogonadotropic hypogonadism with anosmia. This high-resolution method covers the entire coding region and splice sites, enabling accurate diagnosis, prognosis, and family risk assessment.

Feature Our Test (NGS) Closest Alternative (Sanger Sequencing)
Precision (Analytical Sensitivity) 99.9% – Full gene sequencing 95% – Limited to known mutations
Methodology Next‑Generation Sequencing (NGS) with copy number variant analysis Sanger sequencing of selected exons
Turnaround Time 3 to 4 Weeks 4 to 6 Weeks (often longer)

Physician Insight & Safety Protocols

“As a DHA‑licensed consultant medical genetics, I attest that this FGFR1 gene test identifies pathogenic variants with high accuracy, forming the cornerstone of Kallmann syndrome diagnosis and family counseling. Remember, all genetic results must be correlated with your complete clinical picture.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Advisory: Medication Caution

Do not discontinue or adjust any prescribed medication (hormonal therapy, fertility drugs, etc.) without explicit instruction from your personal physician. This test provides genetic information, not immediate therapeutic directives.

Exclusion Criteria & Emergency Red Flags

  • Patients with active suicidal ideation or severe untreated psychiatric disorder should be stabilized prior to genetic testing.
  • Inability to provide informed consent or absence of a legally authorized representative for minors (per UAE medical liability regulations under Federal Decree-Law No. 4 of 2016) is exclusionary.
  • If you experience acute psychological distress, depression, or self‑harm thoughts after result disclosure, seek emergency medical care immediately or call 998.
  • Pregnancy is not a contraindication, but prenatal genetic counseling is mandatory per Federal Decree-Law No. 4 of 2016 on Medical Liability.

Patient FAQ & Clinical Guidance

1. What is the purpose of testing the FGFR1 gene?

The FGFR1 gene test identifies mutations causing Kallmann syndrome type 2, enabling diagnosis, prognosis, and family risk assessment.

2. How is the sample collected?

A blood sample or buccal swab is collected by a certified phlebotomist during a VIP home visit, with temperature-controlled cold-chain transport.

3. What does a positive FGFR1 result mean?

A pathogenic FGFR1 mutation confirms Kallmann syndrome, guiding hormone therapy and fertility options, though not all mutations show full penetrance.

UAE Regulatory & Data Privacy Adherence

This genetic test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent is obtained in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE is a DHA-licensed facility (License No. 1143) operating under the regulatory oversight of the Dubai Health Authority.

Clinical & Logistical Metadata

Test Name FGFR1 Gene (Kallmann Syndrome Type 2) Genetic Test
Price (AED) 2,800 AED
Turnaround Time 3 to 4 Weeks
Sample Type / Matrix Whole Blood or Buccal Swab
Methodology Used Next-Generation Sequencing (NGS) – Full gene coverage with CNV analysis
ICD-10-CM Code E23.0 (Hypogonadotropic hypogonadism), R43.0 (Anosmia)
LOINC Code 77999-5 (FGFR1 gene mutation analysis)
DHA Facility License & Laboratory Address License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians